SCHEMBL1315086

SCHEMBL1315086

CC(C)(C)[Si](C)(C)OCc1cc([C@H](CBr)O[Si](C)(C)C(C)(C)C)ccc1OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 4/20 0.38
ALDH1A1 P00352 2/20 0.37
RAB9A P51151 1/20 0.37
ELANE P08246 1/20 0.37
LMNA P02545 1/20 0.37
SLC6A4 P31645 2/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
HTR7 P34969 1/20 0.34
HTR6 P50406 1/20 0.34
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTR1A P08908 1/20 0.33
DRD2 P14416 1/20 0.33
ALOX5AP P20292 1/20 0.33
USP28 Q96RU2 1/20 0.33
USP25 Q9UHP3 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1315087 1.00 CCR5 (0.38) CCR5ALDH1A1RAB9AELANELMNA
SCHEMBL4016266 0.89 CCR5 (0.42) CCR5ALDH1A1RAB9AELANELMNA
SCHEMBL5969107 0.89 CCR5 (0.42) CCR5ALDH1A1RAB9AELANELMNA
SCHEMBL1309896 0.86 CCR5 (0.40) CCR5ALDH1A1RAB9AELANELMNA
Methylsulfanylmethane SCHEMBL6111453 0.86 CCR5 (0.39) CCR5ALDH1A1RAB9AELANELMNA
SCHEMBL7693480 0.85 ELANE (0.35) CCR5ALDH1A1RAB9AELANELMNA
SCHEMBL5080739 0.85 ELANE (0.35) CCR5ALDH1A1RAB9AELANELMNA
SCHEMBL18227196 0.85 ALOX5AP (0.38) CCR5ALDH1A1RAB9AELANELMNA
SCHEMBL5969600 0.83 FOLH1 (0.48) ALDH1A1ELANEPTGER1
SCHEMBL2566374 0.81 FOLH1 (0.41) ALDH1A1RAB9AELANELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450490-B2 Bi-functional pyrazolopyridine compounds GILEAD SCIENCES, INC. (US) 2013-05-28 US disclosed
US-8450490-B2 Bi-functional pyrazolopyridine compounds GILEAD SCIENCES, INC. (US) 2013-05-28 US disclosed
US-8367829-B2 Bi-functional pyrazolopyridine compounds GILEAD SCIENCES, INC. (US) 2013-02-05 US disclosed
US-8367829-B2 Bi-functional pyrazolopyridine compounds GILEAD SCIENCES, INC. (US) 2013-02-05 US disclosed
US-20130018050-A1 BI-FUNCTIONAL PYRAZOLOPYRIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 2013-01-17 US disclosed
US-20130018050-A1 BI-FUNCTIONAL PYRAZOLOPYRIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 2013-01-17 US disclosed
WO-2011143106-A1 BI - FUNCTIONAL PYRAZOLOPYRIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 2011-11-17 WO disclosed
US-20110275623-A1 BI-FUNCTIONAL PYRAZOLOPYRIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 2011-11-10 US disclosed
US-20110275623-A1 BI-FUNCTIONAL PYRAZOLOPYRIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018050-A1 BI-FUNCTIONAL PYRAZOLOPYRIDINE COMPOUNDS BDKRB2, BDKRB1, P2RX7 CCR5 139/4885ALDH1A1 1413/4885RAB9A 2210/4885
US-20110275623-A1 BI-FUNCTIONAL PYRAZOLOPYRIDINE COMPOUNDS BDKRB2, BDKRB1, P2RX7 CCR5 139/4885ALDH1A1 1413/4885RAB9A 2210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.